Conference Proceedings

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas (MG) (NABTC 04-02)

SM Chang, J Kuhn, K Lamborn, T Cloughesy, I Robins, F Lieberman, A Yung, J Dancey, M Prados, P Wen

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2009